(Q34593882)

3 August 2017

0 references

1 reference

title

A systematic review of antioxidant treatment for amyotrophic lateral sclerosis/motor neuron disease (English)

1 reference

amyotrophic lateral sclerosis

3 August 2017

main subject

1 reference

1 reference

Richard W Orrell

1

1 reference

3 August 2017

Russell J M Lane

series ordinal

2

1 reference

3 August 2017

Mark Ross

series ordinal

3

1 reference

3 August 2017

publication date

1 August 2008

1 reference

Amyotrophic Lateral Sclerosis and Other Motor Neuron Disorders

3 August 2017

published in

1 reference

3 August 2017

volume

9

1 reference

3 August 2017

issue

4

1 reference

3 August 2017

page(s)

195-211

1 reference

Incidence of amyotrophic lateral sclerosis in southern Italy: a population based study.

3 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1080%2F17482960801900032

Amyotrophic lateral sclerosis mortality in the United States, 1979-2001.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17482960801900032

Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17482960801900032

Role of antioxidants in health maintenance

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17482960801900032

Role of free radicals in the neurodegenerative diseases: therapeutic implications for antioxidant treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17482960801900032

Benefit of vitamin E, riluzole, and gabapentin in a transgenic model of familial amyotrophic lateral sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17482960801900032

An open-randomized clinical trial of selegiline in amyotrophic lateral sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17482960801900032

Survival in patients with amyotrophic lateral sclerosis, treated with an array of antioxidants.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17482960801900032

Reduced glutathione in amyotrophic lateral sclerosis: an open, crossover, randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17482960801900032

Vitamin E intake and risk of amyotrophic lateral sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17482960801900032

A double-blind, placebo-controlled randomized clinical trial of alpha-tocopherol (vitamin E) in the treatment of amyotrophic lateral sclerosis. ALS riluzole-tocopherol Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17482960801900032

Meta-analysis: high-dosage vitamin E supplementation may increase all-cause mortality

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17482960801900032

Antioxidant therapy in ALS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17482960801900032

ALS, SOD and peroxynitrite

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17482960801900032

10.1080/17482960801900032

21 January 2018

Identifiers

DOI

1 reference

3 August 2017

1 reference